Canada markets open in 7 hours 57 minutes

Celyad Oncology SA (CYAD.BR)

Brussels - Brussels Delayed Price. Currency in EUR
Add to watchlist
0.3190+0.0185 (+6.16%)
At close: 05:35PM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
44
0
0
5
6
Cost of Revenue
44
0
0
0
0
Gross Profit
0
0
0
5
6
Operating Expenses
Research Development
10,540
18,928
20,773
21,522
25,232
Selling General and Administrative
7,757
10,337
9,665
9,315
8,725
Total Operating Expenses
8,803
20,263
26,909
26,220
29,379
Operating Income or Loss
-8,803
-20,263
-26,909
-26,215
-29,373
Interest Expense
91
197
255
434
343
Total Other Income/Expenses Net
-
-20,422
523
9,228
495
Income Before Tax
-30,554
-40,870
-26,502
-17,204
-28,640
Income Tax Expense
65
65
10
0
-8
Income from Continuing Operations
-30,619
-40,935
-26,512
-17,204
-28,632
Net Income
-30,619
-40,935
-26,512
-17,204
-28,632
Net Income available to common shareholders
-30,619
-40,935
-26,512
-17,204
-28,632
Basic EPS
-1.36
-1.81
-1.70
-1.23
-2.29
Diluted EPS
-1.36
-1.81
-1.70
-1.23
-2.29
Basic Average Shares
22,558
22,594
15,604
13,942
12,523
Diluted Average Shares
22,558
22,594
15,604
13,942
12,523